INDEX TO POSTGRADUATE VOLUME 94 MEDICINE JULY-DECEMBER 1993 SUBJECTS ABDOMEN BODY WEIGHT CHILD ABUSE * Coronary arteriography in eval- e Pain, right upper quadrant, dif- * Loss in elderly—failure to thrive. ¢ Maternal sexual abuse of male —? congestive heart failure. ferential diagnosis. 94(2):153 94(5):201 children, suspecting and uncov- 94(3):77 ACQUIRED IMMUNODEFICIENCY BRONC ering such abuse. 94(1):169* ¢ Fine-needle aspiration biopsy SYNDROME (AIDS) ¢ Chronic, evaluation. 94(8):84* HOLESTEROL for thyroid nodules. 94(1):111* ¢ Kaposi’s sarcoma, report of ¢ Chronic, treatment. 94(8):93°* * Lipid hypothesis of coronary ¢ For benign prostatic hyperpla- case mimicking cellulitis. (CR) atherosclerosis, recent studies. sia. 94(6):142 94(8):139 CALCULI 94(1):50° ¢ Radionuclide angiography to AGING ¢ Biliary stones, nonsurgical CONNECTIVE TISSUE DISEASES evaluate systolic and diastolic ¢ Failure to thrive, identifying fac- treatment with endoscopic and ¢ Pulmonary manifestations, function in congestive heart fail- tors involved and stopping down- radiologic techniques. 94(6):61* prognosis and therapeutic op- ure. 94(3):65 ward spiral. 94(5):199* ¢ Gallstones, nonsurgical treat- tions. 94(5):147* ¢ Rheumatoid factor in diagnosis © Headache in elderly patients, ment methods. 94(6):45" of arthritis, reliability. 94(6):133 recognition and management of CANCER: See Neoplasms DELIVERY OF HEALTHCARE DIET: See Nutrition benign types. 94(8):109* CARDIOVASCULAR © Decoding jargon of healthcare DRUG THERAPY ¢ Hematogenous osteomyelitis e Atherosclerosis, recent find- reform. 94(4):21 © For acute myocardial infarction. in the elderly. 94(5):178 ings on treatment and reversal of ¢ Expanding use of nonphysi- 94(8):59 ¢ Pneumonia, special considera- disease. 94(1):50* cian providers for costs sav- © For control of hyperlipidemia, tions in the elderly. 94(5):39" * Cerebrovascular, cause of ings—worrisome component of recent findings on their effects. ¢ Systolic hypertension in the el- headache in elderly. 94(8):120 health reform. 94(4):128 94(1):56 derly, recent findings from clinical * Congestive heart failure, ad- ¢ Hampered with enlarged DRUGS, ALPHA-AD ic trials on diuretics in treatment. vanced, inpatient treatment and healthcare bureaucracy. (ED) BLOCKER 94(2):143* selection for cardiac transplanta- 94(8):17 ¢ For benign prostatic hyperpla- e Thyroid dysfunction in the sev- tion. 94(5):97 ¢ Healthcare reform, making sia. 94(6):143 erely ill and elderly, diagnosis. * Congestive heart failure, anti- sense of three proposed plans. DRUGS, ANDROGEN SUPPRES- 94(3):111* arrhythmic therapy. 94(5):121* 94(7):32 SANT AIDS: See Acquired immunodefi- © Congestive heart failure, differ- ¢ Malpractice and the new ¢ For benign prostatic hyperpla- ciency syndrome (AIDS) entiating types with noninvasive health reform plan. (ED) 94(1):21 sia. 94(6):144 ANKLE assessment of systolic and dias- ¢ Managed care can be quality |-CONVERT- © Sprains. (PN) 94(2):171 tolic function. 94(3):55* care. 94(7):69 ING ENZYME (ACE) INHIBITOR ANTIBODIES © Congestive heart failure, drug —— care can work. 94(4): ¢ Use after myocardial infarction, e Antinuclear, test, guide to its treatment to ease symptoms and results of drug trials. 94(6):98 use and interpretation of results. improve quality of life. 94(5):66* ¢ Managed care in rural areas— RUGS, ANTIARRHYTHMIC 94(2):55* ¢ Congestive heart failure, when many unknowns. 94(7):91 ¢ For patients with congestive ARTHRITIS: See Rheumatic dis- is invasive testing useful? 94(3): ¢ Patients worry about rationing heart failure plus ventricular ar- eases and long lines 94(7):60 rhythmias. 94(5):121* ¢ Coronary angioplasty in pa- ¢ President Clinton’s healthcare ¢ Use after myocardial infarction, BACK tients with acute myocardial in- plan is bad medicine. (ED) 94(7): results of drug trials. 94(6):97 e Ankylosing spondylitis, recog- farction. 94(8):53 39 DRUGS, ANTIBIOTIC nition and treatment. 94(1):153* * Coronary rehabilitation, new e Primary care by nurses—what ¢ For pneumonia, special con- BEES approaches to care. 94(2):131* will healthcare reform do to the siderations in the elderly. 94(5):43 e Africanized, commonly referred © Lifestyle Heart Trial—effects of front lines of primary care? (ED) ¢ For treatment of erythema mi- to as “killer” bees, migration into life-style and dietary changes on 94(3):23 grans. 94(1):138 U.S., avoiding and treating stings. coronary atherosclerosis. 94(1): ¢ Quality depends on profit mo- e New, single-dose treatment for 94(2):92* 55 tive. 94(4):93 gonorrhea. 94(2):108 BEHAVIORAL MEDICINE ¢ Myocardial infarction, acute, ¢ Recent quotes on healthcare ¢ Role in treatment of chronic ¢ Strategies for helping patients detection and treatment in differ- reform. (ED) 94(2):11 bronchitis. 94(8):97 quit smoking. 94(1):197* ent medical settings. 94(8):51* ¢ Reform may mean reduced © Triple-drug therapy combining BIOPSY ¢ Myocardial reinfarction, pre- quality of medicine. 94(7):65 antibiotics with bismuth to eradi- ¢ Endomyocardial, histologic ev- vention, recommendations based ¢ Rural patients, will healthcare cate Helicobacter pylori and re- idence for cause of congestive on results of oa. 94(6):94"* reform limit access? 94(7):96 duce recurrence of peptic ulcer heart failure. 94(3):78 ¢ Pacemakers. (PN) 94(5):221 * Thoughts on old-fashioned pa- disease, new strategies. 94(3):40 e Fine-needle aspiration biopsy ¢ Popliteal artery aneurysm, tient care and the President’s IRASE for thyroid nodules. 94(1):111* evaluation and treatment. (CR) new health plan. 94(7):81 e For myasthenia gravis. 94(5): BITES AND STINGS 94(2):125 * White House briefing book on 167 e Africanized honeybees, com- * St. Thomas’ Atherosclerosis healthcare reform. (ED) 94(4):35 DRUGS, ANTICOAGULANT monly referred to as “killer” bees, Regression Study (STARS)— ¢ Who will advocate for patients e After myocardial infarction, migration into U.S., avoiding and effects of life-style and dietary in managed-care environments? current recommendations. 94(6): treating stings. 94(2):92* changes on coronary atheroscle- 94(7):108 94 BODY WEIGHT rosis. 94(1):55 ¢ Will personal freedom survive DRUGS, ANTIDEPRESSANT © Loss in elderly—failure to thrive. ¢ Systolic hypertension in the el- reform? 94(7):131 ¢ Tricyclic, in management of 94(5):201 derly, recent findings from clinical o EPRESSION depression. 94(3):87 trials on diuretics in treatment. ¢ Current diagnostic criteria and DRUGS, ANTIEMETIC 94(2):143 treatment options, guidelines for ¢ For alleviating chemotherapy- *Maijor clinical discussion ¢ Temporal (giant cell) arteritis, psychiatric referral. 94(3):85* induced nausea and vomiting. CR, Case Report cause of headache in elderly. DIAGNOSTIC TECHNIQUES 94(5):55* ED, Editorial 94(8):119 e Antinuclear antibody test, guide DRUGS, ANTIHYPERLIPIDEMIC PH, Physician-at-Large CHEMOTHERAPY: See Drugs, an- to its use and interpretation of re- ¢ Use after myocardial infarction. PN, Patient Notes tineoplastic sults. 94(2):55* 94(6):102 continued VOL 94/NO 8/DECEMBER 1993/POSTGRADUATE MEDICINE 183 INDEX TO VOLUME 94 CONTINUED DRUGS, ANTIINFLAMMATORY DRUGS, VASODILATOR discomfort with antiemetic drug ¢ Physician autonomy crucia! to ¢ In treating chronic bronchitis. ¢ For congestive heart failure. regimens. 94(5):55* healthcare reform. 94(4):128 94(8):96 94(5):70 e Primary sclerosing cholangitis ¢ Positive aspects of healthcare OPLASTIC and primary biliary cirrhosis, trials reform and managed care. 94(4): ¢ Adjuvant chemotherapy for ECHOC APHY of medical treatment to arrest rectal cancer. 94(1):187 * Noninvasive assessment of progression. 94(6):81* e President Clinton’s healthcare ¢ Chemotherapy-induced nau- systolic and diastolic function in e Rectal cancer, recent ad- plan is bad medicine. (ED) 94(7): sea and vomiting, easing fear differentiating types of conges- vances and future trends in ther- 39 and discomfort with antiemetic tive heart failure. 94(3):63 apy. 94(1):183* © Profit motive essential to quali- drug regimens. 94(5):55* ELDERLY: See Agi e Right upper quadrant abdomi- ty care. 94(4):93 DRUGS, BETA BLOCKER EMERGENCY MEDICINE nal pain, differential diagnosis. ¢ Pushing physicians into prima- ¢ -For congestive heart failure. ¢ Acute myocardial infarction, 94(2):153* ry care and healthcare reform. 94(5):81 detection and treatment in differ- GENITAL 94(4):82 e Use after myocardial infarction, ent medical settings. 94(8):51* ¢ Prostatitis, characteristics, di- e Recent quotes on healthcare results of Norwegian Multicenter ENDOCRINE DISORDERS agnosis, and treatment. 94(5):191* reform. (ED) 94(2):11 Study. 94(6):94 ¢ Evaluation using newer thyroid ¢ Sexually transmitted diseases. ¢ Reform debate, making sense DRUGS, BRONCHODILATOR function tests. 94(1):81* (PN) 94(6):157 of three proposed pians. 94(7):32 ¢ For chronic bronchitis. 94(8):94 ¢ Hypothyroidism. (PN) 94(1):207 GERIATRICS: See Aging e Reform may mean reduced DRUGS, CALCIUM CHANNEL * Hypothyroidism, early signs GYNECOLOGY: See Obstetrics/ quality of medicine. 94(7):65 BLOCKER camouflaged by Parkinson’s Gynecology ¢ Say “No” to enlarged health- e For congestive heart failure. disease. (CR) 94(5):187 care bureaucracy! (ED) 94(8):17 94(5):81 © Subclinical, overview. 94(1):95* HEADACHE ¢ Single-payer system—answer e Use after myocardial infarction, ¢ Thyroid dysfunction in the se- e In elderly patients, recognition to problems of uninsured? 94(4): drug trial results. 94(6):96 verely ill and elderly, diagnosis. and management of benign types. 77 DRUGS, CORTICOSTEROID 94(3):111* 94(8):109* ¢ Single-payer system ultimately ¢ For patients with myasthenia ¢ Thyroid nodules, fine-needle © Migraine: See Migraine better health reform measure gravis. 94(5):168 aspiration biopsy in diagnosis HEALTH POLICY than managed care. 94(7):81 DRUGS, DIGIT. ALIS and management. 94(1):111* * Bigger isn’t better. 94(7):103 ¢ Surviving solo practice in the e For congestive heart failure. ENDOSCOPY © Clinton plan inspires fear of ra- midst of healthcare reform. 94(4): 94(5):78 ¢ Endoscopic sphincterotomy tioning. 94(7):60 123 DRUGS, DIURETIC for bile duct stone removal. 94(6): © Decoding jargon—key concepts ¢ White House briefing book on e For congestive heart failure. 61 of healthcare reform. 94(4):21 healthcare reform. (ED) 94(4):35 94(5):77 EPILEPSY ¢ Farewell to “Cadillac” health- ¢ Who will advocate for patients ¢ In treatment of systolic hyper- ¢ Latest medical and surgical op- care. 94(7):85 in managed-care environments? tension in the elderly, recent find- tions for management. 94(3):97°* © Fears of more government in- 94(7):108 ings from clinical trials. 94(2):143* EXERCISE trusion. 94(4):63 e Will healthcare reform be the DRUGS, DOSAGE REGIMENS ¢ Rehabilitation for coronary pa- e Financing healthcare reform end of first-class medical care? e Adjusting in patients with renal tients. 94(2):131 with high cigarette taxes. (ED) 94(4):51 insufficiency to prevent drug- e Vigorous, cause of rhabdomy- 94(5):13 e Will personal freedom survive induced side effects. 94(8):153* olysis, diagnosis and treatment. © Healthcare reform and changes reform? 94(7):131 DRUGS, IMMUNOSUPPRESSIVE (CR) 94(6):128 in doctor-patient relationships. © Will reform limit access for ru- © Effective treatment for autoim- 94(7):115 ral patients? 94(7):96 mune myasthenia gravis. 94(5):170 GALLBLADDER s ¢ Healthcare reform and tough HEART DISEASE: See Cardiovas- DRUGS, NONSTEROIDAL ANTIIN- ¢ Biliary obstruction, nonsurgical business climate. 94(4):71 cular diseases FLAMMATORY (NSAIDs) treatment with endoscopic and e Lessening government regula- HEMATOLOGIC DISEASES ¢ For ankylosing spondylitis. radiologic methods. 94(6):61* tions and changing patient ex- ¢ Pulmonary infiltrates in im- 94(1):159 © Gallstones, nonsurgical treat- pectations may be positive as- munocompromised patients. © To prevent gallstone formation ment methods. 94(6):45° pects of reform. 94(4):117 94(1):69"* and treat symptomatic gallblad- ¢ Management with prosta- ¢ Make patients pay their share, HEPA TITIS der disease. 94(6):52 glandin inhibitors. 94(1):127* take responsibility. 94(7):120 ¢ B, relationship to hepatocellu- DRUGS, ORAL DISSOLUTION ¢ Primary sclerosing cholangitis ¢ Malpractice and healthcare re- lar carcinoma. 94(8):71 ¢ Chenodeoxycholic acid for and primary biliary cirrhosis, trials form—how will enterprise liability HYPERTENSION: See Cardiovas- gallstone dissolution. 94(6):47 of medical treatment to arrest work? (ED) 94(1):21 cular diseases ¢ Ursodeoxycholic acid for gail- progression. 94(6):81* © Managed care can be quality stone dissolution. 94(6):48 GASTROINTESTINAL care. 94(7):69 e Evaluation using newer thyroid DRUGS, SIDE EFFECTS ¢ Biliary obstruction, nonsurgical ¢ Managed care component function tests. 94(1):87 © Chemotherapy-induced nau- treatment with endoscopic and must allow flexibility. 94(4):101 HYPOTHYROIDISM sea and vomiting, easing fear radiologic methods. 94(6):61* ¢ Managed care in rural areas— ¢ Early signs camouflaged by and discomfort with antiemetic © Gallbladder disease, manage- many unknowns. 94(7):91 Parkinson’s disease, report of a drugs. 94(5):55* ment with prostaglandin inhibi- * Observing firsthand the Presi- case. (CR) 94(5):187 e Reducing in patients with renal tors. 94(1):127* dent deliver his new health plan. e Evaluation using newer thyroid insufficiency, altering dosage reg- ¢ Gallstones, nonsurgical treat- (ED) 94(6):13 function tests. 94(1):82 imens to prevent toxic accumula- ment methods. 94(6):45* © Optimism in the face of reform. « In the severely ill and elderly. tions of drugs. 94(8):153* © Helicobacter pylori and peptic 94(4):58 94(3):115 THROMBOLYTIC ulcer disease, rethinking man- ¢ Perspectives on hassle-free ¢ Patient information. (PN) 94(1): ¢ Intravenous, to reduce early agement. 94(3):38* medical practice—managed care. 207 mortality after acute myocardial * Nausea and vomiting, chemo- 94(4):87 ¢ Subclinical, overview. 94(1):95* infarction. 94(8):52 therapy-induced, easing fear and VOL 94/NO 8/DECEMBER 1993/POSTGRADUATE MEDICINE INFECTION nosis and therapeutic options. NURSES PROSTAGLANDINS ¢ Bacterial, lower respiratory 94(5):147* ¢ On front lines of providing pri- e Use in managing gallbladder tract, special considerations in mary care? (ED) 94(3):23 disease. 94(1):127* the elderly. 94(5):39* MALPRACTICE NUTRITION PROSTATIC ¢ Bacterial prostatitis, acute and ¢ Enterprise liability in the new ¢ Malnutrition and weight loss in ¢ Benign prostatic hyperplasia, chronic, diagnosis and treatment. healih reform plan. (ED) 94(1):21 the elderly—failure to thrive. 94(5): update on new medical therapies 94(5):191 MEDICAL PRACTICE 01 and surgical interventions. 94(6): e Cause of pulmonary infiltrates ¢ Advantages of reform. 94(4): 141° in immunocompromised patients, 108 OBSTETRICS/GYNECOLOGY ¢ Characteristics of prostatitis, an individualized approach. 94(1): ¢ Hassle-free with managed * Chronic pelvic pain, differenti- diagnosis and treatment. 94(5): 69* care. 94(4):87 ating anatomic from functional ¢ Gonorrhea, ideas for improving ¢ Profit motive essential to quali- causes. 94(8):125* PSYCHIATRIC/PSYCHOSOCIAL prevention and detection, treat- ty care. 94(4):93 * Toxic shock syndrome, recog- DISORDERS ment with single-dose oral antibi- ¢ Proposed healthcare reform nition of staphylococcal and * Depression, current diagnostic otics. 94(2):105* plan puts government between streptococcal forms. 94(6):107* criteria and treatment options, © Helicobacter pylori and peptic doctors and patients. (ED) 94(8): e Uterine fibroids, diagnostic guidelines for psychiatric referral. ulcer disease, rethinking man- 17 techniques, latest developments 94(3):85* agement. 94(3):38* ¢ Will healthcare reform put in medical treatment. 94(3):129* ¢ Maternal sexual abuse of male ¢ Human immunodeficiency nurses on front lines of primary ONCOLOGIC DISEASES: See Neo- children, suspecting and uncov- virus, manifested by Kaposi’s care? (ED) 94(3):23 plasms ering such abuse. 94(1):169* sarcoma. (CR) 94(8):139 MIGRAINE ¢ Psychogenic, or functional, ¢ Lyme disease, recognition of e In elderly patients, recognition PAIN causes of pelvic pain, differenti- erythema migrans key to early di- and treatment. 94(8):110 ¢ Abdominal, right upper quad- ating from anatomic causes. agnosis. 94(1):133" MUSCULOSKELETAL DISORDERS rant, differential diagnosis. 94(2): 94(8):125* ¢ Osteomyelitis, antibiotic and e Ankle sprains. (PN) 94(2):171 PSYCHOTHERAPY surgical treatment. 94(5):177* ¢ Ankylosing spondylitis, recog- ¢ Back, differentiating ankylosing © For depression. 94(3):89 ¢ Sexually transmitted diseases. nition and treatment. 94(1):153* spondylitis from other causes, di- PULMONARY DISEASES: See (PN) 94(6):157 ¢ Myasthenia gravis, diagnostic agnosis and treatment. 94(1):153* Lung diseases; Respiratory dis- © Toxic shock syndrome, char- methods, therapeutic options. * Headache in elderly patients, eases acteristics of staphylococcal and 94(5):161* recognition and management of streptococcal forms, recognition ¢ Osteomyelitis, antibiotic and benign types. 94(8):109" RADIOGRAPHY and treatment. 94(6):107* surgical treatment. 94(5):177* ¢ Pelvic, chronic, differentiating * Gallstone extraction through T- ¢ Rhabdomyolysis after exer- anatomic from functional causes. tube tract under fluoroscopic JOINTS cise, diagnosis and treatment. 94(8):125* guidance. 94(6):69 e Rheumatoid arthritis, early di- (CR) 94(6):128 PATIENT EDUCATION RADIOTHERAPY agnosis important in long-term ¢ Rheumatoid arthritis, early di- e Ankle sprains. (PN) 94(2):171 e Adjuvant to surgery in treat- outcome. 94(8):165* agnosis important in long-term * Crucial component of modern ment of rectal cancer. 94(1):186 outcome. 94(8):165* coronary rehabilitation. 94(2):135 ¢ For malignant biliary obstruc- KIDNEY DISEASES © Head lice. (PN) 94(3):143 tion. 94(6):72 ¢ Renal insufficiency, reducing NEOPLASMS ¢ Helping patients quit smoking. RECTAL DISEASES drug-induced side effects by al- ¢ Hepatocellular carcinoma, (PN) 94(1):197* ¢ Cancer, recent advances and tering dosage tegimen. 94(8):153* identifying and screening at-risk ¢ Hypothyroidism. (PN) 94(1):207 future trends in therapy. 94(1):183* populations. 94(8):71* * Pacemakers. (PN) 94(5):221 REHABILITATION LABORATORY INVESTIGATION e Intracranial tumors, cause of ¢ Preventing holiday poisoning. ¢ Coronary, new approaches. e Antinuclear antibody test, headache in elderly. 94(8):120 (PN) 94(8):199 94(2):131* guide to its use and interpreta- * Kaposi‘s sarcoma mimicking * Sexually transmitted diseases. RENAL DISEASE: See Kidney dis- tion of results. 94(2):55* cellulitis. (CR) 94(8):139 (PN) 94(6):157 eases ¢ Pulmonary function testing in e Rectal cancer, recent ad- PATIENTS RESPIRATORY DISEASES evaluation of chronic bronchitis. vances and future trends in ther- ¢ Taking responsibility for their ¢ Chronic bronchitis, clinical 94(8):90 apy. 94(1):183* health and the costs. 94(7):120 evaluation. 94(8):84* e Rheumatoid factor in diagnosis e Thymoma, in patients with PEDIATRICS ¢ Chronic bronchitis, current of rheumatoid arthritis. 94(8):169 myasthenia gravis. 94(5):162 ¢ Head lice. (PN) 94(3):143 pharmacologic approaches to LICE ¢ Thyroid nodules, fine-needle * Hematogenous osteomyelitis management. 94(8):93* * Head. (PN) 94(3):143 aspiration biopsy in diagnosis in children, diagnosis and treat- * Chronic obstructive pulmonary LIVER DISEASES and management. 94(1):111* ment. 94(5):177* disease, major goals of manage- e Hepatocellular carcinoma, ¢ Uterine fibroids, diagnostic ¢ Maternal sexual abuse of male ment. 94(2):113* identifying and screening at-risk techniques, latest developments children, suspecting and uncov- ¢ Pneumonia in the elderly, spe- populations. 94(8):71* in medical treatment. 94(3):129* ering such abuse. 94(1):169* cial considerations. 94(5):39* ¢ Primary sclerosing cholangitis NEUROLOGIC MANIFESTATIONS ¢ Preventing holiday poisoning. RHEUMATIC DISEASES and primary biliary cirrhosis, trials ¢ Entrapment neuropathies, di- (PN) 94(8):199 ¢ Acute gouty arthritis, diagnosis of medical treatments to arrest agnosis and treatment. 94(2):39" PHYSICIAN-PATIENT RELATIONS and treatment. 94(2):73* progression. 94(6):81* ¢ Epilepsy, medical and surgical ¢ Changes coming with health- e Ankylosing spondylitis, recog- LUNG DISEASES options for modern management. care reform. 94(7):115 nition and treatment of this cause ¢ Chronic obstructive pulmonary 94(3):97° POISONING of back pain. 94(1):153* disease, major goals of manage- *° Headache: See Headache ¢ Prevention during holidays. e Antinuclear antibody test in di- ment. 94(2):113* ¢ Myasthenia gravis, diagnostic (PN) 94(8):199 agnosing rheumatic and non- e Pulmonary manifestations of methods, therapeutic options. PRIMARY CARE rheumatic diseases, use and in- connective tissue disease, prog- 94(5):161* ¢ Pushing physicians into prima- terpretation of results. 94(2):55* ry care. 94(4):82 continued VOL 94/NO 8/DECEMBER 1993/POSTGRADUATE MEDICINE 185 INDEX TO VOLUME 94 CONTINUED ¢ Connective tissue disease, vanced congestive heart failure. TRANSPLANTATION UROLOGIC DISEASES pulmonary manifestations, prog- 94(5):105 © Cardiac, indications for in pa- ¢ Benign prostatic hyperplasia, nosis and therapeutic options. * Focal resection and commis- tients with advanced congestive update on new medical therapies 94(5):147° surotomy in surgical manage- heart failure. 94(5):105 and surgical interventions. 94(6): ¢ Entrapment neuropathies, di- ment of epilepsy. 94(3):106 ¢ Liver, for advanced cases of 141° agnosis and treatment. 94(2):39* e For rectal cancer, recent ad- primary sclerosing cholangitis ¢ Prostatitis, characteristics, di- ¢ Lyme disease, recognition of vances. 94(1):183 and primary biliary cirrhosis. agnosis, and treatment. 94(5):191* erythema migrans key to early di- ¢ Hysterectomy for uterine fi- 94(6):84, 88 agnosis. 94(1):133* broid removal, considerations. TRAUMA VASCULAR DISEASES: See Car- e Rhabdomyolysis, diagnosis 94(3):132 e Ankle sprains. (PN) 94(2):171 diovascular diseases and treatment, report of case ¢ Liver transplantation for ad- TUMORS: See Neoplasms VENEREAL DISEASES: See Sexu- caused by vigorous exercise. vanced cases of primary scleros- ally transmitted diseases (CR) 94(6):128 ing cholangitis and primary biliary ULCER ¢ Rheumatoid arthritis, causes cirrhosis. 94(6):84, 88 ¢ Peptic, eradicating Helicobac- and clinical course, diagnostic ¢ Program on Surgical Control of ter pylori to reduce recurrence, considerations for optimum man- the Hyperlipidemias (POSCH), re- rethinking management. 94(3):38* agement. 94(8):165* cent findings. 94(1):60 ¢ Rheumatoid factor in diagnosis e Prostate, new procedures to of arthritis, reliability. 94(6):133 treat benign prostatic hyperpla- sia. 94(6):144 SCREENING ¢ Thymectomy in myasthenia ¢ For hepatocellular carcinoma, gravis patients. 94(5):167 methods. 94(8):72 SEIZURES TECHNOLOGY MEDICAL © Types in epilepsy, latest medi- ¢ Pacemakers. (PN) 94(5):221 AUTHORS cal and surgical management op- THERAPEUTICS tions. 94(3):97 e Extracorporeal shock wave SEXUAL ABUSE lithotripsy for gallstone dissolu- ¢ Of boys by their mothers, sus- tion. 94(6):49 pecting and uncovering such e Fine-needle aspiration biopsy ADAMS EM JK abuse. 94(1):169* in management of thyroid nod- See Parachuri R The facts about fibroids: Pre- SEXUALLY TRANSMITTED Dis- ules. 94(1):111* AJLUNI SC sentation and latest management EASES ¢ Measures for improving quality See Kahn JK options. 94(3):129* * Gonorrhea, ideas for improving of life for patients with chronic ALMANY SL CLARK RF prevention and detection, treat- obstructive pulmonary disease. See Kahn JK See Tunget CL ment with single-dose oral antibi- 94(2):116 ALPERT MA CONTI JB otics. 94(2):105* ¢ Plasmapheresis, short-term See Mukerji B Antiarrhythmic therapy in pa- * Patient information. (PN) 94(6): option for myasthenia gravis. ANDERSON EG tients with congestive heart 157 94(5):170 Germ warfare. (PH) 94(6):23 failure. 94(5):121* SKIN DISEASES THYROID DISEASES Hat trick. (PH) 94(3):28 Cc RAGG DR ¢ Erythema migrans, key to early ¢ Dysfunction in the severely ill Out of character. (PH) 94(1):27 See Kahn JK diagnosis of Lyme disease. 94(1): and elderly, diagnosis. 94(3):111* Snow jobs. (PH) 94(8):27 CURTIS AB 33* ¢ Hypothyroidism. (PN) 94(1):207 AREPALLY G See Conti JB * Kaposi's sarcoma mimicking ¢ Hypothyroidism, early signs See Oehler RL CUSHING GW cellulitis. (CR) 94(8):139 camouflaged by Parkinson’s dis- Hypothyroidism. (PN) 94(1):207 SMOKING ease. (CR) 94(5):187 BABB R Subclinical hypothyroidism: ¢ Cause of chronic bronchitis. ¢ Nodules, fine-needle aspiration Managing gallbladder disease Understanding is the key to deci- 94(8):88 biopsy in diagnosis and manage- with prostaglandin inhibitors. sion making. 94(1):95* ¢ Cessation, in chronic bronchi- ment. 94(1):111* 94(1):127* CUSHMAN WC tis, essential to preserve pul- ¢ Subclinical hypothyroidism, BAKRIS GL Systolic hypertension in the el- monary function. 94(8):93* overview. 94(1):95* Drug dosing in patients with derly: Safe treatment with low- ¢ Helping patients quit, four-step THYROID FUNCTION TESTS renal insufficiency: A simplified dose thiazide diuretics. 94(2):143 approach to behavior modifica- ¢ Application of newer methods approach. 94(8):153* tion. 94(1):197"* in evaluation of hypothyroidism, BAMBERGER DM DePAOLIS M * Taxing cigarettes to help fi- hyperthyroidism, and nonthy- Osteomyelitis: A commonsense Home healing. (PH) 94(5):25 nance healthcare reform. (ED) roidal iliness. 94(1):81* approach to antibiotic and surgi- When doctors get sick. (PH) 94(5):13 ¢ in diagnosing hypothyroidism cal treatment. 94(5):177* 94(2):29 SPECIALTIES, MEDICAL in seriously ill and elderly pa- DePAULO JR Jr ¢ Effects of reform—pushing tients. 94(3):117 See Simpson SG physicians into primary care. ¢ In diagnosing thyrotoxicosis in DUNN ve 94(4):82 the severely ill and elderly. 94(3): See Taylor AJ See Oehler RL SUICIDE 111 mans s ¢ Management of risk in de- TOXIC SHOCK SYNDROME ‘apy-ind: d nausea EGBERT AM pressed patients. 94(3):89 ¢ Recognition of staphylococcal rm vomiting: Easing patients’ ‘The dwindles’: Failure to thrive SURGERY and streptococcal forms, treat- fear and discomfort with effective in older patients. 94(5):199* ¢ Cardiac transplantation, indi- ment. 94(6):107* antiemetic regimens. 94(5):55* ELKINS TE cations for in patients with ad- See Nolan TE VOL 94/NO 8/DECEMBER 1993/POSTGRADUATE MEDICINE ELLIOTT AJ ISLEY WL Prostatitis: Sorting out the differ- SMITH CS Maternal sexual abuse of male Thyroid dysfunction in the ent causes. 94(5):191* Hepatocellular carcinoma: children: When to suspect and severely ill and elderly: Forget MUKERJI B Identifying and screening popula- how to uncover it. 94(1):169* the classic signs and symptoms. When the lungs are involved by tions at increased risk. 94(8):71* ESCALANTE A 94(3):111* connective tissue disease. SONI SN Ankylosing spondylitis: A com- 94(5):147* Rhabdomyolysis after exercise. mon cause of low back pain. JAFFE PE MURALI S (CR) 94(6):128 94(1):153* Gallstones: Who are good can- Invasive testing in congestive STASZEWSKI H didates for nonsurgical treat- heart failure: When is it useful? Diffuse pulmonary infiltrates in FALLON BG ment? 94(6):45* 94(3):75* See Bilgrami S JENNISON SH Reconciling theory and practice. FEDOTIN MS What to try while congestive NOLAN TE 94(1):69°* Helicobacter pylori and peptic heart failure patients are still Chronic pelvic pain: Differentiat- STEVENSON LW ulcer disease: Reexamining the ambulatory. 94(5):66* ing anatomic from functional Advanced congestive heart therapeutic approach. 94(3):38" JUHN MS causes. 94(8):125* failure: Inpatient treatment and FENNERTY MB Myasthenia gravis: Diagnostic selection for cardiac transplanta- Primary sclerosing cholangitis methods and control measures OEHLER RL tion. 94(5):97 and primary biliary cirrhosis: for a chronic disease. 94(5):161* Kaposi’s sarcoma mimicking STRAUSBAUGH How effective is medical thera- cellulitis. (CR) 94(8):139 Toxic shock syndrome: Are you py? 94(6):81* KAHN JK recognizing its changing presen- FLAKER GC Aggressive treatment of acute PAAUW DS tations? 94(6):107* Prevention of myocardial rein- myocardial infarction: Manage- See Smith CS farction: Recommendations ment options for various settings. PARACHURI R TALBERT R based on results of drug trials. 94(8):51* Entrapment neuropathies: A See Bakris GL 94(6):94* Reversing coronary atheroscle- guide to avoiding misdiagnoses. TAN N rosis: How to put findings of re- 94(2):39* Acute gouty arthritis: Modern GRAZIANO FM cent trials to practical use. 94(1): PETERSON LW approaches to an ancient dis- See Vikingsson A 50° See Elliott AJ ease. 94(2):73* GRIFFIN GC KAYE TB TANDETER HB ‘Clinton & Clinton’ tort reform: Thyroid function tests: Applica- RATHGABER S Parkinson’s disease camou- An imaginary conversation be- tion of newer methods. 94(1):81* Right upper quadrant abdomi- flaging early signs of hypothy- tween Bill and Hillary. (ED) 94(1):21 KRONENBERG RS nal pain: Diagnosis in patients roidism. (CR) 94(5):187 dCloi natognr,e eG riofnf in,s oNmaed ert,h inagnsd. D(oElDe) Cinh reovanliuca tiobnr.o nc9h4i(t8i)s:8:4 Key points wit3h"o ut evident gallstones. 94(2): TNAoYnLiOnRv aAsJi ve assessment of 94(5):13 See also Griffith DE REX DK systolic and diastolic function: Decoded, the President’s plan See Rathgaber S Important clues to differentiating is bad medicine for Americans. LERTRATANAKUL Y RINGEL M types of congestive heart failure. (ED) 94(7):39 See Tan N Ankle sprains. (PN) 94(2):171 94(3):55* Head lice. (PN) 94(3):143 LISSE JR ROBINSON JA THOMAS C It’s not the law of the land—yet! Does rheumatoid factor always See Thomas C The antinuclear antibody test: (ED) 94(4):35 mean arthritis? 94(6):133 RUOFF GE When is a positive result clinically Now do something! 94(7):137 Headache in elderly patients: relevant? 94(2):55* The ‘salesman-in chief’ sells a McCUE JD How to recognize and manage TUNGET CL health plan. (ED) 94(6):13 Pneumonia in the elderly: Spe- benign types. 94(8):109* Invasion of the ‘killer’ bees: Scary quotes about healthcare cial considerations in a special Separating fact from fiction. that may go down in history. population. 94(5):39* SAROEA HG 94(2):92* (ED) 94(2):11 McDONALD E Chronic obstructive pulmonary Your ‘family doctor’ may be a See Soni SN disease: Major objectives of VIKINGSSON A nurse! (ED) 94(3):23 MARINO C management. 94(2):113 Rheumatoid arthritis: |mpor- GRIFFITH DE See Soni SN SEDDON AM tance of early diagnosis in long- Chronic bronchitis: Choosing MASTERS EJ Popliteal artery aneurysm: term outcome. 94(8):165* the optimal treatment. 94(8):93* Erythema migrans: Rash as key Prompt intervention prevents See also Kronenberg RS to early diagnosis of Lyme dis- tragic consequences. (CR) 94(2): WENGERN K GRIFFITH RS ease. 94(1):133* 125 Modern coronary rehabilita- Sexually transmitted diseases. MIEDEMA BW SEXE R tion: New concepts in care. (PN) 94(6):157 See Sexe R Rectal cancer: Treatment ad- 94(2):131* MILLER LW vances that reduce recurrence WONG JG See Jennison SH rates and lengthen survival. How to help your patients quit MILLS RM Jr 94(1):183* smoking: Strategies that work. Congestive heart failure: To- SHVARTZMAN P 94(1):197* Gonorrhea: Finding and treating day’s approaches and tomor- See Tandeter HB WOOL MS a moving target. 94(2):105* row's directions. 94(3):49 SIMPSON SG Thyroid nodules: The place of HIXSON LJ Pacemakers. (PN) 94(5):221 Are you recognizing depres- fine-needle aspiration biopsy in Biliary obstruction: Nonsurgical MOUL JW sion in your patients? 94(3):85* management. 94(1):111* treatment with endoscopic and Benign prostatic hyperpiasia: SINGH VN WYLER AR radiologic techniques. 94(6):61* New concepts in the 1990s. See Flaker GC Modern management of epi- 94(6):141* SINNOTT JT lepsy: Recommended medical See Oehler RL and surgical options. 94(3):97* VOL 94/NO 8/DECEMBER 1993/POSTGRADUATE MEDICINE